The European Partnership for Personalised Medicine, EP PerMed, supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its first research, innova-tion and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisa-tions participate in this call with an available budget of over 1 4.8 Mio. € (approx.). EP PerMed funding organisations, listed below, have agreed to jointly fund multinational innovative research and technology projects in personalised medicine (PM) to encourage innovative, interdisciplinary public-private partnerships and to support the translational and clinical implementation of research outcomes.

The South African Medical Research Council’s Research Capacity Development Initiative (RCDI) provides an opportunity for researchers at institutions previously and/or currently constrained by inadequate access to resources to access funds that will enable the institutions and researchers to improve their contribution to the generation of new knowledge towards addressing priority health challenges in South Africa and to build overall health research capacity within the institutions. To date, the programme has supported researchers from eight selected HDIs, including University of Limpopo, University of Venda, University of Zululand, University of Fort Hare, Walter Sisulu University, University of the Western Cape, Mangosuthu University of Technology and Sefako Makgatho University.

The SAMRC invites eligible EMUs to submit applications to ensure that the negative impact of the funding cuts is minimised, and that research momentum is preserved for the benefit of South Africa and beyond.

Together with the Australian National Health and Medical Research Council (NHMRC), the South African Medical Research Council (SAMRC) is inviting investigators to submit applications with a focus on implementation research, addressing strategies for strengthening of health systems to improve equity in high quality care and health outcomes and reduce the prevalence and impact of non-communicable diseases.